EMA – Publication of the presentation materials, the report and the video recording of the Joint EC/HMA/EMA multi-stakeholder workshop on pharmacogenomics held the 24 September 2024
The European Commission (EC), the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) organised a multi-stakeholder hybrid workshop on Pharmacogenomics at EMA in Amsterdam the 24 September 2024.
The objectives of the workshop were to:
-
- identify priority areas for additional regulatory action to promote the clinical implementation of pharmacogenomics;
- discuss how medicines regulators can facilitate the uptake of genomics by national healthcare systems;
- discuss how to leverage genomic data linked to real-world data sources with examples of current studies using such data;
- discuss how to increase the regulatory impact of EU-funded projects in personalised medicine.
The EMA published all the presentation materials and the video recordings of the event on its Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (26 mars 2025). EMA – Publication of the presentation materials, the report and the video recording of the Joint EC/HMA/EMA multi-stakeholder workshop on pharmacogenomics held the 24 September 2024. ELSIBI. Consulté le 19 janvier 2026 à l’adresse https://doi.org/10.58079/13kne





